Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Parkinsonism Relat Disord. 2021 Aug 21;91:13–18. doi: 10.1016/j.parkreldis.2021.08.011

Table 1.

Participant Characteristics by Disease Type and Stage

HD Disease Type HD Disease Stage
Non-HD Controls
(N = 4,958)
All HD
(N = 14,791)
CAG 36–39
(N = 833)
CAG 40–59
(N = 13,862)
CAG ≥ 60
(N = 96)
Premanifest
(N = 5,612)
Early Stage
(N = 6,696)
Mid Stage
(N = 1,911)
Late Stage
(N = 572)
Sleep Disturbance Prevalence 277 (5.6) 2312 (15.6) 119 (14.3) 2166 (15.6) 27 (28.1) 472 (8.4) 1124 (16.8) 516 (27.0) 200 (35.0)
Age (y) 46.6 (14.8) 48.2 (13.9) 55.1 (15.3) 47.9 (13.6) 24.6 (4.2) 40.5 (12.4) 51.9 (12.3) 54.8 (13.0) 56.6 (13.4)
Sex (F) 3006 (61.1) 7994 (54.0) 468 (56.2) 7476 (53.9) 50 (52.1) 3318 (59.1) 3310 (49.4) 1034 (54.1) 332 (58.0)
History of Alcohol Use (%) 2761 (56.2) 7696 (52.0) 512 (61.5) 7163 (51.7) 21 (21.9) 3524 (62.8) 3348 (50.0) 706 (36.9) 118 (20.6)
History of Tobacco Use (%) 2126 (43.2) 7090 (47.9) 379 (45.5) 6672 (48.1) 39 (40.6) 2534 (45.2) 3344 (49.9) 936 (49.0) 276 (48.3)
Depression Subscore 3.4 (5.1) 5.0 (6.3) 3.9 (5.6) 5.0 (6.3) 3.9 (5.2) 4.6 (6.1) 5.2 (6.2) 5.4 (6.8) 5.4 (6.3)
Psychosis Subscore 0.1 (0.7) 0.3 (1.5) 0.1 (0.5) 0.3 (1.6) 0.4 (1.6) 0.1 (1.1) 0.2 (1.4) 0.5 (2.2) 0.9 (3.0)
SDMT Score 50.0 (12.1) 32.2 (17.7) 41.3 (17.3) 31.7 (17.6) 19.5 (11.4) 48.0 (12.9) 26.3 (11.2) 14.3 (8.9) 5.0 (6.5)

Data are presented as mean (SD) for continuous variables and N (%) for categorical variables. The statistical difference in in sleep disturbance prevalence, sex, history of alcohol use, and history of tobacco use were determined using the chi-squared test while the one-way ANOVA test was used for all other parameters. In each comparison to the Non-HD Controls, all groups were statistically significantly different with p value < 0.001. SDMT – Symbol Digit Modality Test